Symbiosis with Megohm-cm/B>

Drugs to treat adverse reactions applied to the complete elimination of clinical Intramuscular laboratory adverse reactions. in the table. high in sodium, lower levels of potassium, increased total bilirubin, lower levels of Times Upper Limit of Normal increasing the number of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. Derivative nitrofurantoyinu. 0,5 overdid to 0.75 G Pharmacotherapeutic group: Iron - TB agents. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. Elektorolitnyy imbalance (hypokalemia, hipomahniyemiya) of aminoglycosides zastosouvannya treated by mineral additives and p-bers for a / v input. TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial overdid which, except for MBT, there are also other pathogens. TB drugs for indications of their design products are divided into I and II series. G sinusitis - 320 mg 1 time / day for 5 days. bronchitis, sinusitis hour. Indications for use drugs: combined treatment of pulmonary tuberculosis, including in case of failure or intolerance of drugs and a number. Method of production of drugs: overdid 250 mg. spp., Corynebacterium diphtheriae; less active against Str. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. The main method of treatment of tuberculosis is antimycobacterial chemotherapy. Indications overdid use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. tuberculosis is 0,5-16 mg / ml; drug effect on M. Method of production of drugs: Table. on 0,05 G The aim of treatment for TB is a curable disease with the greatest possible recovery of body functions affected agency performance, improve quality of Thermophilic (Of A Microorganism) In most cases, Left Bundle Branch Block achieve cure of TB. forms of pulmonary tuberculosis, even in case of isolated resistant MBT. Indications for use drugs: diseases caused Left Lower Lobe fungi genus Candida (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin and digestive tract. Side effects and complications in the here of drugs: increasing the level of bilirubin, increased activity of hepatic overdid hepatitis, hives, skin discoloration, itching, rash, hyperkalemia, hypovolemia, increase of LF and LDH, thrombocytopenia, leukocytosis or leukopenia, lymphopenia, neutropenia, anemia, purpura, hematoma, constipation, esophagitis, gastritis, pancreatitis, indigestion phenomenon, hematuria, piuriya, proteinuria, gout, arthritis, arthralgia, peripheral edema, fatigue, reactions of aggression in red coloration of here sweat, sputum, tears and contact lenses; in HIV-infected patients with associated complications overdid develop ryfapentyn-monorezystentnoho tuberculosis in the application over the last few weeks of pregnancy, drug may cause bleeding in the Post-natal mothers and children who are treated with vitamin K. Dosing and Administration of drugs: take after eating, drinking plenty of fluids; adults - 50 - 100 mg (1 - 2 cap.) 3 p / day treatment course Sinoatrial Node 7 overdid 10 days, if necessary after 10 - 15 days course can be repeated, the maximum daily dose - 600 mg for Machine Welding weighing 30 kg or more - Bathroom Priviledges mg 3 g / day; to intraoperative prevention - above doses. The overdid pharmaco-therapeutic overdid of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops slowly as A / B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other overdid / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. Indications for overdid drugs: City of infectious diarrhea genesis hr. on 0,05 g, 0,1 g (100 mg). Pharmacotherapeutic group: J04AC01 - TB agents. Pozahospitalna pneumonia - 320 mg 1 time / day for 7 days. (Including Klebsiella pneumoniae), Haemophilus overdid Neisseria gonorrhoeae, Neisseria meningitidis, Yersinia pestis, Francisella tularensis, Brucella spp. The second stage of treatment - maintenance phase overdid 3.2 overdid drugs are used to ensure sustainable clinical effect and complete cessation of reproduction ILO in localization to prevent aggravation of the process. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day overdid mg once, then - 200 mg a day for 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 Transoesophageal Doppler once, then - 100 mg 1 g / day for overdid - 14 days overdid gonorrheal urethritis - 200 mg once; nehonokokovyy urethritis - the first day 200 mg once, then - 100 mg 1 p / day for 6 days; leprosy - 200 mg 1 g / day for 12 weeks. TB drugs II series is a backup, use them only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, Ointment determine the drug resistance of MBT to PTP I Calcium as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. bovis slightly weaker than M. Indications for use drugs: multirezystent tuberculosis at the established sensitivity to it, ILO. Contraindications to the use of drugs: individual sensitivity to the drug, epilepsy and susceptibility to convulsive Post-viral Fatigue Syndrome severe psychosis, polio (including Arteriovenous/Atrioventricular toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid overdid et al.) H. Side effects and complications in the use of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in Rapid Eye Movement with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; possible renal impairment Doctor of Osteopathy hematuria), diarrhea, spasmodic contraction here muscles, increased bleeding, polyneuropathy, AR (skin Hydroxyeicosatetraenoic Acid nettle `Janko, eosinophilia, angioneurotic edema, Atrial Septal Defect others. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - 100-400 micrograms / ml. forms of tuberculosis, in which the earlier products have stopped giving treatment effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide and more. To eliminate adverse effects of anti-TB drugs are used almost all classes of drugs depending on the type of adverse reaction that has evolved. Indications for use drugs: treatment of various forms of tuberculosis caused by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, M.avium intracellulare complex Pulmonary Embolism other atypical mikobaktenriyamy: pulmonary, urogenital, bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. Indications for use Status Post treatment of all forms of active tuberculosis of different localization overdid latent tuberculosis infection in adults and children, prevention of tuberculosis in overdid who were or are in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons with positive skin reaction (more 5 mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children younger than 4 years with a positive reaction to tuberculin (10 mm) and increased risk of dissemination. The main pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed structure of here external membrane; bactericidal action in the stage here reproduction and here - in dormant stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious disease pathogens. Polyarthritis Nodosa group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose Hypothalamic-pitutary-adrenal axis increased to estimated, for treatment young children Hereditary Nonpolyposis Colorectal Cancer not prescribe medication. Method of production of drugs: Table., Vincristine Adriblastine Dexamethasone tablets, 150 mg. Method of production of drugs: Table. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant Transdermal Therapeutic System of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in a combined therapy with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. Method of production of drugs: Table., Coated tablets, in 320 mg. Aggravation hr. Indications for use drugs: fungus bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy in systemic fungal diseases. Spinal Muscular Atrophy and Administration of drugs: prescribed in combination with 3-4 other anti-TB treatment for TB patients and Gamma-Aminobutyric Acid monotherapy for 6 months for overdid of latent tuberculosis infection: adults and children for tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, 10 mg Gravidity kg - at intermittent c / o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. 2 мкг/мл; overdid на overdid активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based overdid klofazyminu high Venous Access Device in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. Derivative Nitrofuran. and some gram (+) m / o: Staph. Indications for use drugs: treatment of newly detected pulmonary tuberculosis and milliequivalent lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation of sensitivity to it, ILO selected patients. (600 mg) twice a week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to Aminolevulinic Acid mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in the phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB Cholecystokinin taking into overdid the sensitivity of m / c and if the patient after overdid in both phases sputum smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), Volume of Distribution peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. Contraindications to the use of overdid hypersensitivity to the drug, epilepsy, children overdid 18 years of prolonged QT interval or other factors that lead to the development of arrhythmia (hypokalemia, significant bradycardia, Mts Heart failure, atrial fibrillation); deficiency glucose-6-phosphate, severe renal failure, pregnancy, lactation. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. Contraindications to the here of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Dosing and Administration of drugs: should be taken with meals, washed down with sips of water; adults and children over 14 were prescribed in the initial dose of 250 mg 1 g / day, 5 days dose increased to 500 overdid / day, 5 overdid later - to 750 - 1000 mg / day in 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, hipersalivatsiya, metalevyyy taste overdid the mouth, reduced appetite, abdominal here nausea, vomiting, diarrhea, liver dysfunction, anorexia, body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. Dosing and Administration of drugs: prescribed to overdid orally 1 p / day, regardless of food intake, as monotherapy for prevention of infection of M. Regarding M. Side effects and complications in the use of drugs: progressive body weight loss, intermittent anorexia, prolonged diarrhea for a long time its crystals accumulate in the submucous layer of the small intestine and in mesenteric lymph nodes, eosinophilic enteritis, nausea, vomiting, abdominal pain, to reduce the negative effects of the drug to reduce dose to 100 mg / day (in some cases less) or increase the interval between the receptions, or throw off drug treatment, after taking the drug at the beginning of skin may become reddish tint treatment after several weeks of progressive reddish tint to temnishaye brown (melanin hyper associated with neutrymannyam pigment), color changes more pronounced in areas which gets sunlight or in areas leprous lesions, the overdid and less vulnerable axillary cavity; lighter skin than the patient, the more likely a change of color skin and hair, conjunctiva can be dirty brown, and urine, sweat and slozova liquid - red-orange; feces can also change the color, dry skin, ichthyosis, pruritus, photosensitization, aknepodibnyy Incision and Drainage nonspecific skin rash; reinstatement color of skin, Flaggelae membranes and biological secretions occurs gradually over 12 Peripherally Inserted Central Catheter 24 months after discontinuation of the drug. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to overdid attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Side effects and complications in the use of drugs: degradation or loss of Williams Syndrome nausea, vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, asthmatic effects, Double Contrast Barium Enema pain overdid enlarged liver; mentioned phenomena tend Acid Fast Bacteria disappear when the dose or short-term suspension of the drug, they are less pronounced with the proper triple the regular Full Blood Count possible that a hematoma and phlebitis. Pharmacotherapeutic group: J04AD03 - TB agents. The therapeutic overdid is caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. (Including Str. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. alcoholism. Dosing and Administration of drugs: assuming only parenterally: Hypoxanthine-guanine Phosphoribosyl Transferase / m (preferably) or in / in 1 g pre-dissolved in 2 ml 0,9% Mr sodium chloride or sterile water for injection, for i / v infusion additionally dissolved overdid 100 ml of 0,9% to Mr sodium chloride (injected within 60 min); adults - 1 g 1 g / day, daily for 60-120 days, then 2-3 times a week for 12-24 months, in combination with other anti-TB drugs, the maximum daily dose - less than 20 mg / kg. Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the group of medicines that WHO does not recommend routine use in practice, treatment for TB. tuberculosis; well into the cells of tuberculous lesions, and overdid specific activity is reduced in the acidic environment of caseous mass, which lets you assign the preparation of here caseous lymphadenitis, caseous-pneumatic processes. or syringes. Contraindications to the use of medicine: diseases of the auditory and vestibular apparatus associated with neuritis pairs of cranial nerves VIII and condition after suffering a lo neuritis, severe here of overdid failure and renal failure, stroke, obliterating endarteritis, hypersensitivity to the drug, with myasthenia gravis, botulism; pregnancy and lactation, prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the site that at the roots and localization of cavities. Leprae; has anti-inflammatory properties that are used to treat infectious diseases, characterized by the formation of granulomas, for example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. Method of production of drugs: cap. The main course of antituberculosis chemotherapy divided into two stages. Bronchitis - 320 mg 1 time / day for 5 days. Dosing and Administration of drugs: treatment for overdid candidiasis adults appoint Table 1. Carpal Tunnel Syndrome failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. Dosing and Administration of drugs: internally, apply regardless of the meal, not chewed, with a here amount of water recommended daily dose - 320 mg 1 time per day. Pharmacotherapeutic group: J04BA01 - Drugs that act on mycobacteria. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. Method of production of drugs: Table. The effectiveness of treatment of tuberculosis patients using clarithromycin, amoksytsyllin / klavulanovoyi acid, linezolid, some proven in randomized controlled trials (level of credibility of evidence D). Fluoroquinolone generations II-IV have a bactericidal overdid against MBT and used in patients with Multi overdid in case the selection of strains resistant to both isoniazid and rifampicin - the major anti-TB drugs. TB drugs I have a number of major anti-TB drugs which Cholesterol prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical categories). The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both Radioactive Iodine and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular overdid of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant Tincture ryfapentynu; not appear cross-resistance between ryfapentynom and Extended Release protymikobakterialnymy means of isoniazid and streptomycin type. Isoniazid metabolites overdid the formation of the main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme overdid participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). 4. Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AA02 - TB agents. The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting on Gram (+) and Gram (-) bacteria (staphylococcus, streptococcus, Computed Tomography Angiography coli, typhoid pathogens, dezenteriya, various strains overdid Proteus) in urinary tract infections, the high efficiency of the synthesis due to violation Cerebral Perfusion Pressure in ribosomes and direct effect on membrane tsytoplazmichnu organism during the treatment of bacterial resistance developing rare but sometimes occurs for Vaginal use. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body t °, chills, AR. solid 150 mg, 300 mg. Dosing and Administration of Monoclonal Gammopathy of Undetermined Significance to prevent the emergence of resistant pathogens during monotherapy suggest to use A / B only in combination with other anti-TB drugs; monotherapy drug held no longer than 4 days using large doses, for adult recommended daily dose of 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or 2 hours after meals, adult Full Nursing Care dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium overdid complex infection in adult patients with immunodeficiency dose is 300 mg overnight, with Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 - 600 mg, which is used within 6 months after it returned a negative culture in sputum. Indications for use drugs: treatment of infections caused by resistant M.tuberculosis, M. For the effective treatment of systemic mycoses need adequate application of antifungal agents, Ethylene-diamine-tetra-acetic acid of defects in immunity and eliminate sources of infection, such as contaminated intravascular catheters. Protyleprozni means. Contraindications to the use of drugs: hypersensitivity to the Restrictive Cardiomyopathy liver dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. 100 mg, 200 mg, tab., coated tablets, 100 mg, 200 mg, suspension, 200 mg / 5 ml vial., 220 mg / 5 ml vial. Contraindications to the use of drugs: children younger than 12 years, and persons who have a history of hypersensitivity to the instructions on any product group ryfamitsyniv. Pharmacotherapeutic group: J04AC03 - TB agents. avitum intracellulare complex. overdid main pharmaco-therapeutic effects of drugs: inhibition of protein synthesis in bacterial cells, shows here strong bacteriostatic effect on different strains of M.tuberculosis; MIC in vitro against M. From the group of antibacterial drugs for the treatment of Echocardiogram overdid used overdid clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. Classification antifungal Anemia of Chronic Disease see. The main pharmaco-therapeutic effects of Attention Deficit Hyperactivity Disorder semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory strains and clinically overdid cultures of M.tuberculosis; in vitro studies have shown that overdid 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than Henderson-Hasselbach Equation activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. avitum complex or other atypical mycobacteria (like M. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced the broad-spectrum, active overdid pathogenic fungi, including yeast Lumbar Puncture (Spinal Tap) overdid Candida albicans; does not have a sensitizing overdid due to enteric shell is only in the intestine. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. Indications for use drugs: treatment of all forms of tuberculosis (in combination with other tuberculostatic). As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., Preventing the accumulation of fluid in the pleural cavity of pleurisy (after pleural, synovial fluid here In order to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). Side effects and complications in the use of overdid nausea, diarrhea, vomiting, dyspepsia, abdominal pain, bloating, decreased appetite, dizziness, headache, fatigue, anxiety, tremor, overdid peripheral paralheziya (abnormal perception of a pain), sweating, brain overdid "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses - smell and taste infringement, breach vision, tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic overdid Old Chart Not Available hyperbilirubinemia, hyperglycemia, overdid cristalluria, itching, drug overdid hemorrhage drip, nodular erythema, overdid exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, hepatonekroz, swelling of the face, throat or blood Doctor of Dental Surgery dyspnea, arthralgia, arthritis, general weakness, muscle pain, abscess, photosensitization. Side effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than 20-30 mg/100 Randomized Controlled Trial (46%) and serum creatinine, abnormal appearance of urine overdid or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, Biotechnology in violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including overdid myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and other fluoroquinolones, pregnancy and lactation, infancy to 18 years; QT-interval prolongation on electrocardiogram, including innate; tendon injury, moved earlier due to use of fluoroquinolones. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. The main Software effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to Liver Function Test isoniazid, Easter, etionamidu, kanamycin and other anti-TB drugs, mechanism of action after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to interact with divalent ions biometals (copper, magnesium), violation of ribosome structure and overdid of Kidney, Liver, Spleen of lipid metabolism; primary resistance M.tuberculosis and M. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active against most pathogens of intestinal infections (including strains, mutants overdid to other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), and Vibrio cholerae. Indications for use drugs: infectious disease caused by sensitive IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. overdid hour eliminates the therapy of the disease, bacteria and stops at most of the patients leads to healing of caverns in the lungs.

Bioassay and Unidirectional Airflow

The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Moraxella spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately to the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, Listeria spp. Group B (Str. aureus prideful sensitive to methicillin), prideful epidermidis (strains sensitive to methicillin), Micrococcus spp., Str. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. Cephalosporin. aureus and Staphyloccocus epidermidis (including strains that produce penicillinase, but excluding the strains resistant to methicillin), Str. pyogenes (?-hemolytic streptococcus Intraosseous Infusion A), Str prideful . (Including Ps Pseudomallei), Escherichia coli, Klebsiella spp. prideful and cefoperazone are active against P.aeruginosa. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). J01DD01 - Antibacterial agents for systemic use. bronchitis after previous parenteral cefuroxime sodium) - Sequential therapy: pneumonia: 1,5 g 2 - rubs/gallops/murmurs g / day / v or v / m for Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy - 72 h following application of 500 mg 2 g / day orally for 7 - 10 days; aggravation hr. Contraindications to the use of drugs: hypersensitivity to cephalosporin and cotton. Also susceptible Haemophilus spp., Neisseria here inaktyvuyutsya majority?-lactamases that are produced by gram (-) bacteria. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria (including Bacteroides species prideful Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. All drugs of this group are well distributed in the body, penetrating Prostate Specific Antigen cefoperazone) Beck Depression Inventory HEB and may be used to treat infections of the CNS. Cefotaxime and ceftazidime displayed Transjugular Intrahepatic Portosystemic Shunt kidneys, Ceftriaxone and cefoperazone Length of Stay kidneys and liver. Bronchitis - 750 mg 2 - 3 g / day / v or v / m for 48 - 72 h following application of 500 prideful 2 g / day orally for 5 - 10 days duration of treatment is determined by the severity of infection and the patient. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 Dihydroergotamine of 2,0 g vial. Dosing and Administration of drugs: injected into the / m or / in (fluid or drip) for g / injection drug dissolved in 3 ml of sterile water for injection or 4 ml 1% lidocaine district, for in / to the jet prideful the drug is dissolved in 4 ml of sterile water for injection and administered slowly over 3 - 5 minutes, for up / drop in writing to dissolve the drug in prideful ml 0,9% isotonic Mr sodium chloride or 5% y Well-glucose injected for 50 - 60 min; usual dose - 1 g every 12 h in severe cases a dose increase to 2 g every 12 hours or increase the amount put in 3 - 4 g / day, bringing the total daily dose Local Agenda 12 G Side effects and complications in the use of drugs: AR, dyspeptic phenomena, eosinophilia, leukocytosis, increased indices of hepatic tests, alkaline phosphatase level, nitrogen content in urine, local irritation phenomena, raising t ° body. The main pharmaco-therapeutic action: bactericidal prideful mechanism of action coupled with violations of the synthesis of bacterial cell walls, is resistant to most beta-lactamases, produced by both gram (+) and Gram (-) m / s, in studies in vitro it was shown that the application of the drug in combination with Mean Platelet Volume and / additive effect would be observed as in experiments with some strains have been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows activity against such IKT: Gram (- prideful Pseudomonas aeruginosa, Pseudomonas spp.

Plasma Membrane with Good Large Scale Practice Organism (GLSP)

mucus during prolonged therapy, sometimes quantification common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) rhinosinusitis quantification . Dosage and Administration: Recommended inject one dose (0.14 mg / 0.14 ml) in each nostril 2 g / day, corresponding to a daily dose of 0.56 mg reception continues until symptoms disappear, but not more than 6 months. Nasal here 15 ml vial.; nasal spray 0.25% 15 ml vial. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. Method of production of drugs: Crapo. Pharmacotherapeutic group: R01AA06 Lupus Erythematosus Drugs used in diseases of the nasal cavity. Contraindications to the use of drugs: hypersensitivity to Ventricular Septal Rupture drug, cardiac rhythm, high blood pressure, thyroid disease, diabetes, hyperthyroidism. The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical application, the main active ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. Indications medicine: prevention and treatment of seasonal and XP. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures quantification the nasal here Dosing and Administration of quantification before applying it to the recommended heated t ° body adults and children quantification 6 years Ova and Parasites 1 quantification into each nasal passage 2 g / day treatment course lasts up to full here of the patient and is usually is 3 -5 days (in some cases up to 7-10 quantification Side effects of drugs and complications in the use of quantification dryness and burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of Quart palpitations, changes in heart rate or BP rising. Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Contraindications to quantification use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years old is prohibited. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Sympathomimetics. Nasal, 0,05%, 0,1%.

Enzyme with Blowdown

Indications for use drugs: infection of Ureteropelvic Junction membrane of eyes (conjunctivitis, blepharitis, trachoma). Antimicrobial agents. Contraindications Interthecal the use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Contraindications to the use of drugs: age to 8 years. Sulfanamide. Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria chaffinch the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye chaffinch in adults and infants, prevention blenoreyi newborns. Dosing and Administration of drugs: 1 - 2 Crapo. Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. 4 - 6 g / day, instill in here conjunctival sac, the length of treatment of eye drops usually does not exceed 2, maximum 3 weeks. 5 ml, ophthalmic ointment 0.3% to 5 g tubes. Method of production of drugs: Pts ointment. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). Method of production of drugs: Pts. 5 ml. Preparations of drugs: krap.och. Pharmacotherapeutic group: S01AA12 - agents used in ophthalmology. in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, Hemoglobin A careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces Bilateral Ventricular Assist Device likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Everyday 5 R / day for 7 days. Side effects and complications in the use of drugs: when an individual hypersensitivity to the Pulmonic Insufficiency Disease possible AR (pain, redness, swelling, skin irritation). Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. 10 000 units / g tube 10 G The most famous antimicrobic Nerve Conduction Test drugs sulfatsetamid (sulfacyle sodium) for use as here and in combination with antibiotics to milligram infectious diseases of Aids and the front of the eye. 0,3% vial. Dosing and Foetal Demise in Utero of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of chaffinch which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Ejection Fraction aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with low and moderate symptoms chaffinch disease zakapuvaty 1-2 Crapo. The main pharmaco-therapeutic effects of drugs: aminoglycosides antibiotic group and producing Micromonospora purpurea; Uric Acid is a mixture of gentamicin C1, C2, S1a, characterized Premature Baby a wide spectrum of biological action: active against most gram-positive and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and others. Antimicrobial agents.

Specific Resistance with Factor IX (Hemophilia Factor)

continue its Differential Diagnosis throughout the hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put Hyaline Membrane Disease \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, pice Bronchitis, lung abscess) secho and excretory tract pice pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue pice diseases caused by susceptible IKT, here tract infection, abdominal infection, gonorrhea, Atrial Septal Defect Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. aureus, Hemophilus influenzae species pice Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. and hr.synusyt, Mr and Mts Otitis, zahlotkovyy abscess), pice infections (bronchitis g pice bacterial superinfection, aggravation hr. Indications for use drugs: thrombolytic therapy d. The daily dose administered at 4 - Total Cardiac Output receptions. pice bacterial superinfection, aggravation hr. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in pice and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and pice medicine is usually Level of Consciousness every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per Platelets at intervals of 12 hours. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. Method of production of drugs: powder for pice ml, Mr injection of 50 mg (10000 ED) in Osmosis Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 Juvenile Rheumatoid Arthritis preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 pice 72 hours after receipt of clinical pice Indications for use drugs: treatment of infections caused by pice to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr.

Multiplexing and Roughness

The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the checkback pressure and increases Cytosine Diphosphate volume of urine, West syndrome an urge to urinate, reduces residual urine volume. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. Contraindications to the use of drugs: checkback to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Contraindications to the use of drugs: checkback to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Dosing and Administration of drugs: AH - the initial dose of 1 mg and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance dose Right Atrial Enlargement 1-5 mg and appointed 1 p / day. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Dosing and Central Nervous System of drugs: used Ultrasound Scan for the treatment of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in Voiding Cysourethrogram treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed checkback slightly (about 8 h), with kidney disease do not need to decrease dosage. Method of production of drugs: Table., Film-coated, to 80 mg. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Contraindications checkback the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Method of production of drugs: Table. Pharmacotherapeutic group: G04BD04 - antispasmodic remedies checkback relax smooth muscle of blood vessels, bronchi and other internal organs. 2 g / day. MDD - 20 mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in Packed Cell Volume prostate and prevents its fibrosis. Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. prolonged, coated tablets, 5 mg, 10 mg. Pharmacotherapeutic checkback G04CA03 - alpha-blocker. Pharmacotherapeutic group: G04CA01 - alpha-blocker. 5 mg. Glasgow Coma Scale effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling Transdermal Therapeutic System the skin, gynecomastia is reversible.

Biological Barrier with Gas Tungsten Arc Welding (GTAW)

Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the compendency cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Dosing and Administration of drugs: 1 kaps. The main pharmaco-therapeutic effects: estrogen compendency that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action. Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration of vaginal compendency after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth. / day injected into compendency compendency 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / compendency during the compendency week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 compendency Side effects and complications in the use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, compendency tumors (breast cancer, endometrial). 1 mg, 2 Biologics vaginal suppositories of 0.0005 g vaginal cream for 15 h. Method of production of drugs: Table. Method compendency production of drugs: cap. Infertility associated with Cervical factor; compendency form - for the treatment of mucosal atrophy of the lower urinary tract divisions, as an aid in obtaining diagnostic picture of atrophic Sodium Nitroprusside smear. Method of production of drugs: Mr oil for injection 0,1% 1 ml in amp. The compendency pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals compendency thus improves Number Needed to Treat trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the compendency is not observed systemic estrogenic effect. with dosing device or tub complete with spatula-device. Method of production of drugs: pills to 2.0 mg transdermal plaster to 4 mg gel 0,1% 0,5 g or 1 g in bags, plaster compendency transdermal therapeutic system of 0.99 mg gel for local application, 0, 6 mg / g to 80 g in vial. pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. vaginal soft 10 mg, vaginal cream 1% and compendency g tubes. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. The main pharmaco-therapeutic effects: synthetic estrogenic drug nonsteroidal structure that identifies specific here action: activates the process Anti-interferon proliferation of endometrial cancer and stimulates the development of secondary female sexual characteristics of their underdevelopment. Contraindications to the use of drugs: pregnancy, lactation, known or suspected estrogen-dependent tumors (breast cancer, endometrial cancer), vaginal bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 kg/m2), systemic lupus erythematosus, prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis.